Condition
Anal High Grade Squamous Intraepithelial Lesion
Total Trials
3
Recruiting
1
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
P 1 (2)
P 2 (1)
Trial Status
Completed1
Recruiting1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05555862Phase 2Active Not RecruitingPrimary
Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL
NCT06626230Phase 1RecruitingPrimary
Safety of Anal Curcumin
NCT04563754Phase 1CompletedPrimary
The Effectiveness of High Resolution Microendoscopy for People Living With HIV
Showing all 3 trials